Chad Robins is Chief Executive Officer and Chairman of Adaptive Biotechnologies Corp (ADPT). The company reported total compensation of $9,081,690 for fiscal year 2025.
| Salary | $698,258 |
|---|---|
| Bonus | $0 |
| Stock awards | $7,675,100 |
| Option awards | $0 |
| Non-equity incentive plan | $703,380 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $4,952 |
| Total | $9,081,690 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Adaptive Biotechnologies Corp filed April 24, 2026, accession 0001193125-26-177409.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Chairman | $698,258 | $0 | $7,675,100 | $0 | $703,380 | $0 | $4,952 | $9,081,690 |
| FY2024 | Chief Executive Officer | $677,918 | $0 | $3,716,313 | $0 | $573,628 | $0 | $5,442 | $4,973,301 |
| FY2023 | Chief Executive Officer | $663,000 | $0 | $7,900,711 | $0 | $318,240 | $0 | $22,316 | $8,904,267 |
| FY2022 | Chief Executive Officer | $658,188 | $0 | $7,668,040 | $0 | $450,840 | $0 | $76,260 | $8,853,328 |
| FY2021 | Chief Executive Officer and Chairman | $600,000 | — | $8,024,916 | — | $492,000 | — | $11,600 | $9,128,516 |
| FY2020 | Chief Executive Officer and Chairman | $597,400 | $0 | $0 | $6,013,620 | $500,000 | $0 | $20,098 | $7,131,118 |
Totals as disclosed in each year's own compensation disclosure for Adaptive Biotechnologies Corp.
| Peer-group chief executive median | $6,714,990 |
|---|---|
| Difference from that median | $2,366,701 |
| Percentile within the disclosed peer group | 75th |
| Peers with a disclosed figure | 19 |
Medians and percentiles are computed across the peer group Adaptive Biotechnologies Corp discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Chad Robins this page | Chief Executive Officer and Chairman | $9,081,690 |
| Harlan Robins | Chief Scientific Officer | $8,509,575 |
| Julie Rubinstein | President and Chief Operating Officer | $4,603,995 |
| Susan Bobulsky | Chief Commercial Officer, MRD | $3,547,558 |
| Kyle Piskel | Chief Financial Officer | $3,310,729 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Adaptive Biotechnologies Corp compensation brief.
Chad Robins's compensation sits inside Adaptive Biotechnologies Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.